APO Research
Talk to an analyst

APO RESEARCH · REPORT

Radioactive Source

A radioactive source is a known quantity of a radionuclide which emits ionizing radiation; typically, one or more of the radiation types gamma rays, alpha particles, beta particles, and neutron radiation.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

A radioactive source is a known quantity of a radionuclide which emits ionizing radiation; typically, one or more of the radiation types gamma rays, alpha particles, beta particles, and neutron radiation.

Selected research

Market Analysis & Forecast

Global Radioactive Source Market Analysis and Forecast 2026-2032

1 January 2026198 pages

Choose your research edition.

Industry ResearchRadioactive Source Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Radioactive Source Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Radioactive Source Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Radioactive Source Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Radioactive Source Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

A radioactive source is a known quantity of a radionuclide which emits ionizing radiation; typically, one or more of the radiation types gamma rays, alpha particles, beta particles, and neutron radiation.

NRG and Mayak maintained absolute dominance in the global radioactive source manufacturers ranking in 2019, together accounted for about 35% of the market share.

Report Includes

Read the full market overview

This report presents an overview of global market for Radioactive Source, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Radioactive Source, also provides the revenue of main regions and countries. Of the upcoming market potential for Radioactive Source, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Radioactive Source revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Radioactive Source market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Radioactive Source revenue, projected growth trends, production technology, application and end-user industry.

Radioactive Source Segment by Company

NRG

Mayak

NTP Radioisotopes

ANSTO

Nordion

IRE

Curium Pharma

Eckert & Ziegler Strahlen

China Isotope & Radiation Corporation (CIRC)

Polatom

Board of Radiation and Isotope Technology

Radioactive Source Segment by Type

Mo-99

Co-60

Na-22

Co-57

Sr-90

I-131

Ir-192

Se-75

Kr-85

Am-241

Radioactive Source Segment by Application

Medical

Industrial

Agriculture

Scientific Research

Others

Radioactive Source Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radioactive Source market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Radioactive Source and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radioactive Source.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Radioactive Source in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Radioactive Source company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Radioactive Source revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Radioactive Source Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Mo-99 Major Player Table 3. Co-60 Major Player Table 4. Na-22 Major Player Table 5. Co-57 Major Player Table 6. Sr-90 Major Player Table 7. I-131 Major Player Table 8. Ir-192 Major Player Table 9. Se-75 Major Player Table 10. Kr-85 Major Player Table 11. Am-241 Major Player Table 12. Global Radioactive Source Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 13. Medical Major Player Table 14. Industrial Major Player Table 15. Agriculture Major Player Table 16. Scientific Research Major Player Table 17. Others Major Player Table 18. Radioactive Source Industry Trends Table 19. Radioactive Source Industry Drivers Table 20. Radioactive Source Industry Opportunities and Challenges Table 21. Radioactive Source Industry Restraints Table 22. Global Radioactive Source Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 23. Global Radioactive Source Market Size by Region (2021-2026) & (US$ Million) Table 24. Global Radioactive Source Market Share by Region (2021-2026) Table 25. Global Radioactive Source Market Size by Region (2027-2032) & (US$ Million) Table 26. Global Radioactive Source Market Share by Region (2027-2032) Table 27. Global Radioactive Source Revenue by Players (US$ Million) & (2021-2026) Table 28. Global Radioactive Source Revenue Market Share by Players (2021-2026) Table 29. Global Radioactive Source Key Players Ranking, 2024 VS 2025 VS 2026 Table 30. Global Radioactive Source Key Players Headquarters & Area Served Table 31. Global Radioactive Source Players, Product Type & Application Table 32. Global Radioactive Source Players Establishment Date Table 33. Global Players Market Concentration Ratio (CR5 and HHI) Table 34. Global Radioactive Source by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Radioactive Source Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Radioactive Source Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Radioactive Source Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Radioactive Source Revenue Market Share by Type (2021-2026) Table 39. Global Radioactive Source Revenue Market Share by Type (2027-2032) Table 40. Global Radioactive Source Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Radioactive Source Revenue by Application (2021-2026) & (US$ Million) Table 42. Global Radioactive Source Revenue by Application (2027-2032) & (US$ Million) Table 43. Global Radioactive Source Revenue Market Share by Application (2021-2026) Table 44. Global Radioactive Source Revenue Market Share by Application (2027-2032) Table 45. NRG Company Information Table 46. NRG Business Overview Table 47. NRG Radioactive Source Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. NRG Radioactive Source Product Portfolio Table 49. NRG Recent Development Table 50. Mayak Company Information Table 51. Mayak Business Overview Table 52. Mayak Radioactive Source Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Mayak Radioactive Source Product Portfolio Table 54. Mayak Recent Development Table 55. NTP Radioisotopes Company Information Table 56. NTP Radioisotopes Business Overview Table 57. NTP Radioisotopes Radioactive Source Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. NTP Radioisotopes Radioactive Source Product Portfolio Table 59. NTP Radioisotopes Recent Development Table 60. ANSTO Company Information Table 61. ANSTO Business Overview Table 62. ANSTO Radioactive Source Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. ANSTO Radioactive Source Product Portfolio Table 64. ANSTO Recent Development Table 65. Nordion Company Information Table 66. Nordion Business Overview Table 67. Nordion Radioactive Source Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Nordion Radioactive Source Product Portfolio Table 69. Nordion Recent Development Table 70. IRE Company Information Table 71. IRE Business Overview Table 72. IRE Radioactive Source Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. IRE Radioactive Source Product Portfolio Table 74. IRE Recent Development Table 75. Curium Pharma Company Information Table 76. Curium Pharma Business Overview Table 77. Curium Pharma Radioactive Source Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Curium Pharma Radioactive Source Product Portfolio Table 79. Curium Pharma Recent Development Table 80. Eckert & Ziegler Strahlen Company Information Table 81. Eckert & Ziegler Strahlen Business Overview Table 82. Eckert & Ziegler Strahlen Radioactive Source Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Eckert & Ziegler Strahlen Radioactive Source Product Portfolio Table 84. Eckert & Ziegler Strahlen Recent Development Table 85. China Isotope & Radiation Corporation (CIRC) Company Information Table 86. China Isotope & Radiation Corporation (CIRC) Business Overview Table 87. China Isotope & Radiation Corporation (CIRC) Radioactive Source Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. China Isotope & Radiation Corporation (CIRC) Radioactive Source Product Portfolio Table 89. China Isotope & Radiation Corporation (CIRC) Recent Development Table 90. Polatom Company Information Table 91. Polatom Business Overview Table 92. Polatom Radioactive Source Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Polatom Radioactive Source Product Portfolio Table 94. Polatom Recent Development Table 95. Board of Radiation and Isotope Technology Company Information Table 96. Board of Radiation and Isotope Technology Business Overview Table 97. Board of Radiation and Isotope Technology Radioactive Source Sales (), Revenue (US$ Million), Price () and Gross Margin (2021-2026) Table 98. Board of Radiation and Isotope Technology Radioactive Source Product Portfolio Table 99. Board of Radiation and Isotope Technology Recent Development Table 100. North America Radioactive Source Revenue by Type (2021-2026) & (US$ Million) Table 101. North America Radioactive Source Revenue by Type (2027-2032) & (US$ Million) Table 102. North America Radioactive Source Revenue by Application (2021-2026) & (US$ Million) Table 103. North America Radioactive Source Revenue by Application (2027-2032) & (US$ Million) Table 104. North America Radioactive Source Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 105. North America Radioactive Source Revenue by Country (2021-2026) & (US$ Million) Table 106. North America Radioactive Source Revenue by Country (US$ Million) & (2027-2032) Table 107. Europe Radioactive Source Revenue by Type (2021-2026) & (US$ Million) Table 108. Europe Radioactive Source Revenue by Type (2027-2032) & (US$ Million) Table 109. Europe Radioactive Source Revenue by Application (2021-2026) & (US$ Million) Table 110. Europe Radioactive Source Revenue by Application (2027-2032) & (US$ Million) Table 111. Europe Radioactive Source Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. Europe Radioactive Source Revenue by Country (2021-2026) & (US$ Million) Table 113. Europe Radioactive Source Revenue by Country (US$ Million) & (2027-2032) Table 114. China Radioactive Source Revenue by Type (2021-2026) & (US$ Million) Table 115. China Radioactive Source Revenue by Type (2027-2032) & (US$ Million) Table 116. China Radioactive Source Revenue by Application (2021-2026) & (US$ Million) Table 117. China Radioactive Source Revenue by Application (2027-2032) & (US$ Million) Table 118. Asia Radioactive Source Revenue by Type (2021-2026) & (US$ Million) Table 119. Asia Radioactive Source Revenue by Type (2027-2032) & (US$ Million) Table 120. Asia Radioactive Source Revenue by Application (2021-2026) & (US$ Million) Table 121. Asia Radioactive Source Revenue by Application (2027-2032) & (US$ Million) Table 122. Asia Radioactive Source Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Asia Radioactive Source Revenue by Region (US$ Million) & (2021-2026) Table 124. Asia Radioactive Source Revenue by Region (US$ Million) & (2027-2032) Table 125. SAMEA Radioactive Source Revenue by Type (2021-2026) & (US$ Million) Table 126. SAMEA Radioactive Source Revenue by Type (2027-2032) & (US$ Million) Table 127. SAMEA Radioactive Source Revenue by Application (2021-2026) & (US$ Million) Table 128. SAMEA Radioactive Source Revenue by Application (2027-2032) & (US$ Million) Table 129. SAMEA Radioactive Source Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. SAMEA Radioactive Source Revenue by Country (2021-2026) & (US$ Million) Table 131. SAMEA Radioactive Source Revenue by Country (US$ Million) & (2027-2032) Table 132. Research Programs/Design for This Report Table 133. Authors List of This Report Table 134. Secondary Sources Table 135. Primary Sources List of Figures Figure 1. Radioactive Source Image Figure 2. Global Radioactive Source Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Radioactive Source Market Size Share 2021 VS 2025 VS 2032 Figure 4. Mo-99 Image Figure 5. Co-60 Image Figure 6. Na-22 Image Figure 7. Co-57 Image Figure 8. Sr-90 Image Figure 9. I-131 Image Figure 10. Ir-192 Image Figure 11. Se-75 Image Figure 12. Kr-85 Image Figure 13. Am-241 Image Figure 14. Global Radioactive Source Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Radioactive Source Market Size Share 2021 VS 2025 VS 2032 Figure 16. Medical Image Figure 17. Industrial Image Figure 18. Agriculture Image Figure 19. Scientific Research Image Figure 20. Others Image Figure 21. Global Radioactive Source Market Size (US$ Million) & (2021-2032) Figure 22. Global Radioactive Source Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 23. Global Radioactive Source Market Share by Region: 2021 VS 2025 VS 2032 Figure 24. Global Radioactive Source Players Revenue Share Top 10 and Top 5 in 2025 Figure 25. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Radioactive Source Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Radioactive Source Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global Radioactive Source Revenue Market Share by Type (2021-2032) Figure 29. Global Radioactive Source Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Radioactive Source Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 31. Global Radioactive Source Revenue Market Share by Application (2021-2032) Figure 32. North America Radioactive Source Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. North America Radioactive Source Revenue Share by Type (2021-2032) Figure 34. North America Radioactive Source Revenue Share by Application (2021-2032) Figure 35. North America Radioactive Source Revenue Share by Country (2021-2032) Figure 36. United States Radioactive Source Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Canada Radioactive Source Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Mexico Radioactive Source Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Europe Radioactive Source Revenue YoY Growth (2021-2032) & (US$ Million) Figure 40. Europe Radioactive Source Revenue Share by Type (2021-2032) Figure 41. Europe Radioactive Source Revenue Share by Application (2021-2032) Figure 42. Europe Radioactive Source Revenue Share by Country (2021-2032) Figure 43. Germany Radioactive Source Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. France Radioactive Source Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. U.K. Radioactive Source Revenue YoY Growth (US$ Million) & (2021-2032) Figure 46. Italy Radioactive Source Revenue YoY Growth (US$ Million) & (2021-2032) Figure 47. Spain Radioactive Source Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. Russia Radioactive Source Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. Netherlands Radioactive Source Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Nordic Countries Radioactive Source Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. China Radioactive Source Revenue YoY Growth (2021-2032) & (US$ Million) Figure 52. China Radioactive Source Revenue Share by Type (2021-2032) Figure 53. China Radioactive Source Revenue Share by Application (2021-2032) Figure 54. Asia Radioactive Source Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. Asia Radioactive Source Revenue Share by Type (2021-2032) Figure 56. Asia Radioactive Source Revenue Share by Application (2021-2032) Figure 57. Asia Radioactive Source Revenue Share by Region (2021-2032) Figure 58. Japan Radioactive Source Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. South Korea Radioactive Source Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. India Radioactive Source Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Australia Radioactive Source Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Taiwan Radioactive Source Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Southeast Asia Radioactive Source Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. SAMEA Radioactive Source Revenue YoY Growth (2021-2032) & (US$ Million) Figure 65. SAMEA Radioactive Source Revenue Share by Type (2021-2032) Figure 66. SAMEA Radioactive Source Revenue Share by Application (2021-2032) Figure 67. SAMEA Radioactive Source Revenue Share by Country (2021-2032) Figure 68. Brazil Radioactive Source Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Argentina Radioactive Source Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Chile Radioactive Source Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Colombia Radioactive Source Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Peru Radioactive Source Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Saudi Arabia Radioactive Source Revenue YoY Growth (US$ Million) & (2021-2032) Figure 74. Israel Radioactive Source Revenue YoY Growth (US$ Million) & (2021-2032) Figure 75. UAE Radioactive Source Revenue YoY Growth (US$ Million) & (2021-2032) Figure 76. Turkey Radioactive Source Revenue YoY Growth (US$ Million) & (2021-2032) Figure 77. Iran Radioactive Source Revenue YoY Growth (US$ Million) & (2021-2032) Figure 78. Egypt Radioactive Source Revenue YoY Growth (US$ Million) & (2021-2032) Figure 79. Years Considered Figure 80. Research Process Figure 81. Key Executives Interviewed

Scope & coverage.

Types
  • Mo-99
  • Co-60
  • Na-22
  • Co-57
  • Sr-90
  • I-131
  • Ir-192
  • Se-75
  • Kr-85
  • Am-241
Applications
  • Medical
  • Industrial
  • Agriculture
  • Scientific Research
  • Others
Companies covered
  • NRG
  • Mayak
  • NTP Radioisotopes
  • ANSTO
  • Nordion
  • IRE
  • Curium Pharma
  • Eckert & Ziegler Strahlen
  • China Isotope & Radiation Corporation (CIRC)
  • Polatom
  • Board of Radiation and Isotope Technology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Radioactive Source Market by Type
  3. 1.2.1 Global Radioactive Source Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Mo-99
  5. 1.2.3 Co-60
  6. 1.2.4 Na-22
  7. 1.2.5 Co-57
  8. 1.2.6 Sr-90
  9. 1.2.7 I-131
  10. 1.2.8 Ir-192
  11. 1.2.9 Se-75
  12. 1.2.10 Kr-85
  13. 1.2.11 Am-241
  14. 1.3 Radioactive Source Market by Application
  15. 1.3.1 Global Radioactive Source Market Size by Application, 2021 VS 2025 VS 2032
  16. 1.3.2 Medical
  17. 1.3.3 Industrial
  18. 1.3.4 Agriculture
  19. 1.3.5 Scientific Research
  20. 1.3.6 Others
  21. 1.4 Assumptions and Limitations
  22. 1.5 Study Goals and Objectives
2 Radioactive Source Market Dynamics
  1. 2.1 Radioactive Source Industry Trends
  2. 2.2 Radioactive Source Industry Drivers
  3. 2.3 Radioactive Source Industry Opportunities and Challenges
  4. 2.4 Radioactive Source Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Radioactive Source Market Perspective (2021-2032)
  2. 3.2 Global Radioactive Source Growth Trends by Region
  3. 3.2.1 Global Radioactive Source Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Radioactive Source Market Size by Region (2021-2026)
  5. 3.2.3 Global Radioactive Source Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Radioactive Source Revenue by Players
  2. 4.1.1 Global Radioactive Source Revenue by Players (2021-2026)
  3. 4.1.2 Global Radioactive Source Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Radioactive Source Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Radioactive Source Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Radioactive Source Key Players Headquarters & Area Served
  7. 4.4 Global Radioactive Source Players, Product Type & Application
  8. 4.5 Global Radioactive Source Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Radioactive Source Market CR5 and HHI
  11. 4.6.3 2025 Radioactive Source Tier 1, Tier 2, and Tier 3
5 Radioactive Source Market Size by Type
  1. 5.1 Global Radioactive Source Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Radioactive Source Revenue by Type (2021-2032)
  3. 5.3 Global Radioactive Source Revenue Market Share by Type (2021-2032)
6 Radioactive Source Market Size by Application
  1. 6.1 Global Radioactive Source Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Radioactive Source Revenue by Application (2021-2032)
  3. 6.3 Global Radioactive Source Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 NRG
  2. 7.1.1 NRG Company Information
  3. 7.1.2 NRG Business Overview
  4. 7.1.3 NRG Radioactive Source Revenue and Gross Margin (2021-2026)
  5. 7.1.4 NRG Radioactive Source Product Portfolio
  6. 7.1.5 NRG Recent Developments
  7. 7.2 Mayak
  8. 7.2.1 Mayak Company Information
  9. 7.2.2 Mayak Business Overview
  10. 7.2.3 Mayak Radioactive Source Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Mayak Radioactive Source Product Portfolio
  12. 7.2.5 Mayak Recent Developments
  13. 7.3 NTP Radioisotopes
  14. 7.3.1 NTP Radioisotopes Company Information
  15. 7.3.2 NTP Radioisotopes Business Overview
  16. 7.3.3 NTP Radioisotopes Radioactive Source Revenue and Gross Margin (2021-2026)
  17. 7.3.4 NTP Radioisotopes Radioactive Source Product Portfolio
  18. 7.3.5 NTP Radioisotopes Recent Developments
  19. 7.4 ANSTO
  20. 7.4.1 ANSTO Company Information
  21. 7.4.2 ANSTO Business Overview
  22. 7.4.3 ANSTO Radioactive Source Revenue and Gross Margin (2021-2026)
  23. 7.4.4 ANSTO Radioactive Source Product Portfolio
  24. 7.4.5 ANSTO Recent Developments
  25. 7.5 Nordion
  26. 7.5.1 Nordion Company Information
  27. 7.5.2 Nordion Business Overview
  28. 7.5.3 Nordion Radioactive Source Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Nordion Radioactive Source Product Portfolio
  30. 7.5.5 Nordion Recent Developments
  31. 7.6 IRE
  32. 7.6.1 IRE Company Information
  33. 7.6.2 IRE Business Overview
  34. 7.6.3 IRE Radioactive Source Revenue and Gross Margin (2021-2026)
  35. 7.6.4 IRE Radioactive Source Product Portfolio
  36. 7.6.5 IRE Recent Developments
  37. 7.7 Curium Pharma
  38. 7.7.1 Curium Pharma Company Information
  39. 7.7.2 Curium Pharma Business Overview
  40. 7.7.3 Curium Pharma Radioactive Source Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Curium Pharma Radioactive Source Product Portfolio
  42. 7.7.5 Curium Pharma Recent Developments
  43. 7.8 Eckert & Ziegler Strahlen
  44. 7.8.1 Eckert & Ziegler Strahlen Company Information
  45. 7.8.2 Eckert & Ziegler Strahlen Business Overview
  46. 7.8.3 Eckert & Ziegler Strahlen Radioactive Source Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Eckert & Ziegler Strahlen Radioactive Source Product Portfolio
  48. 7.8.5 Eckert & Ziegler Strahlen Recent Developments
  49. 7.9 China Isotope & Radiation Corporation (CIRC)
  50. 7.9.1 China Isotope & Radiation Corporation (CIRC) Company Information
  51. 7.9.2 China Isotope & Radiation Corporation (CIRC) Business Overview
  52. 7.9.3 China Isotope & Radiation Corporation (CIRC) Radioactive Source Revenue and Gross Margin (2021-2026)
  53. 7.9.4 China Isotope & Radiation Corporation (CIRC) Radioactive Source Product Portfolio
  54. 7.9.5 China Isotope & Radiation Corporation (CIRC) Recent Developments
  55. 7.10 Polatom
  56. 7.10.1 Polatom Company Information
  57. 7.10.2 Polatom Business Overview
  58. 7.10.3 Polatom Radioactive Source Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Polatom Radioactive Source Product Portfolio
  60. 7.10.5 Polatom Recent Developments
  61. 7.11 Board of Radiation and Isotope Technology
  62. 7.11.1 Board of Radiation and Isotope Technology Company Information
  63. 7.11.2 Board of Radiation and Isotope Technology Business Overview
  64. 7.11.3 Board of Radiation and Isotope Technology Radioactive Source Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Board of Radiation and Isotope Technology Radioactive Source Product Portfolio
  66. 7.11.5 Board of Radiation and Isotope Technology Recent Developments
8 North America
  1. 8.1 North America Radioactive Source Revenue (2021-2032)
  2. 8.2 North America Radioactive Source Revenue by Type (2021-2032)
  3. 8.2.1 North America Radioactive Source Revenue by Type (2021-2026)
  4. 8.2.2 North America Radioactive Source Revenue by Type (2027-2032)
  5. 8.3 North America Radioactive Source Revenue Share by Type (2021-2032)
  6. 8.4 North America Radioactive Source Revenue by Application (2021-2032)
  7. 8.4.1 North America Radioactive Source Revenue by Application (2021-2026)
  8. 8.4.2 North America Radioactive Source Revenue by Application (2027-2032)
  9. 8.5 North America Radioactive Source Revenue Share by Application (2021-2032)
  10. 8.6 North America Radioactive Source Revenue by Country
  11. 8.6.1 North America Radioactive Source Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Radioactive Source Revenue by Country (2021-2026)
  13. 8.6.3 North America Radioactive Source Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Radioactive Source Revenue (2021-2032)
  2. 9.2 Europe Radioactive Source Revenue by Type (2021-2032)
  3. 9.2.1 Europe Radioactive Source Revenue by Type (2021-2026)
  4. 9.2.2 Europe Radioactive Source Revenue by Type (2027-2032)
  5. 9.3 Europe Radioactive Source Revenue Share by Type (2021-2032)
  6. 9.4 Europe Radioactive Source Revenue by Application (2021-2032)
  7. 9.4.1 Europe Radioactive Source Revenue by Application (2021-2026)
  8. 9.4.2 Europe Radioactive Source Revenue by Application (2027-2032)
  9. 9.5 Europe Radioactive Source Revenue Share by Application (2021-2032)
  10. 9.6 Europe Radioactive Source Revenue by Country
  11. 9.6.1 Europe Radioactive Source Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Radioactive Source Revenue by Country (2021-2026)
  13. 9.6.3 Europe Radioactive Source Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Radioactive Source Revenue (2021-2032)
  2. 10.2 China Radioactive Source Revenue by Type (2021-2032)
  3. 10.2.1 China Radioactive Source Revenue by Type (2021-2026)
  4. 10.2.2 China Radioactive Source Revenue by Type (2027-2032)
  5. 10.3 China Radioactive Source Revenue Share by Type (2021-2032)
  6. 10.4 China Radioactive Source Revenue by Application (2021-2032)
  7. 10.4.1 China Radioactive Source Revenue by Application (2021-2026)
  8. 10.4.2 China Radioactive Source Revenue by Application (2027-2032)
  9. 10.5 China Radioactive Source Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Radioactive Source Revenue (2021-2032)
  2. 11.2 Asia Radioactive Source Revenue by Type (2021-2032)
  3. 11.2.1 Asia Radioactive Source Revenue by Type (2021-2026)
  4. 11.2.2 Asia Radioactive Source Revenue by Type (2027-2032)
  5. 11.3 Asia Radioactive Source Revenue Share by Type (2021-2032)
  6. 11.4 Asia Radioactive Source Revenue by Application (2021-2032)
  7. 11.4.1 Asia Radioactive Source Revenue by Application (2021-2026)
  8. 11.4.2 Asia Radioactive Source Revenue by Application (2027-2032)
  9. 11.5 Asia Radioactive Source Revenue Share by Application (2021-2032)
  10. 11.6 Asia Radioactive Source Revenue by Country
  11. 11.6.1 Asia Radioactive Source Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Radioactive Source Revenue by Country (2021-2026)
  13. 11.6.3 Asia Radioactive Source Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Radioactive Source Revenue (2021-2032)
  2. 12.2 SAMEA Radioactive Source Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Radioactive Source Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Radioactive Source Revenue by Type (2027-2032)
  5. 12.3 SAMEA Radioactive Source Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Radioactive Source Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Radioactive Source Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Radioactive Source Revenue by Application (2027-2032)
  9. 12.5 SAMEA Radioactive Source Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Radioactive Source Revenue by Country
  11. 12.6.1 SAMEA Radioactive Source Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Radioactive Source Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Radioactive Source Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst